Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2021; 67(2): 31-36


N.O. Ryzhkova1, T.I. Gavrilenko1, L.V. Yakushko1, O.M. Parkhomenko1, N.V. Dovgan1, O.V. Dovgan1, O.M. Lomakovsky1, Yu.Y. Babchuk2, S.М. Babiy2

  1. State Institution National Scientific Center «M.D. Strazhesko Institute of Cardiology National Academy of Medical Sciences of Ukraine», Kyiv, Ukraine
  2. Taras Shevchenko National University of Kyiv, Ukraine


198 patients with coronary heart disease (stable and unstable angina- UA, acute myocardial infarction-AMI) were examined. The content of interleukin-10 (IL-10) in the supernatants of immunocompetent cells was determined at hospitalization. In patients with unstable angina and myocardial infarction it was also measured on the 7th day of the treatment. A wide range of the indicators was revealed when patients were admitted to hospital. In this regard, the subjects were divided into 2 subgroups: A - with a low content of IL-10 in mononuclear cells (UA - 58.1, AMI - 75.4%), B - with a normal or high content of this cytokine in these cells. In the dynamics of treatment, the indicators in mononuclear cells change depending on the initial value of the concentration of IL-10: its low content increases, high - decreases. On the 7th day of treatment, the content of the studied factor in these cells became almost the same in all subgroups. A low level of the anti-inflammatory cytokine IL-10 at the beginning of the disease is probably a pathogenetic link and a predictor of acute coronary events.

Keywords: coronary heart disease; immunocompetent cells; cytokines; interleukin-10.


  1. Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z. Leukocytederived interleukin-10 is required for protection against atherosclerosis in low-density lipoprotein receptor knokcout mice. Arterioscler Thromb Vasc Biol. 2004;24 (8):474-8. CrossRef PubMed
  2. Han X, Kitamoto S, Lian Q, Boisvert WA. Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages. J Biol Chem. 2009;284 (47): 32950-8. CrossRef PubMed PubMedCentral
  3. Zimmerman MA, Reznikov LL, Raeburn CD, Selzman CH. Interleukin-10 attenuates the response to vascular injury. J Surg Res. 2004;121:206-13. CrossRef PubMed
  4. Wyss CA, Neidhart M, Altwegg L, Spanaus K, Yonekawa K, Wischnewsky MB, Corti R, Kucher N, Roffi M, Eberli F, Amann-Vesti B, Gay S, Eckardstein A, Lüscher T, Maier W. Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J. 2010;31:1457-69. CrossRef PubMed
  5. Cavusoglu E, Marmur J, Hojjati M, Chopra V, Butala M, Subnani R, Huda MS, Yanamadala S, Ruwende C, Eng C, Pinsky DJ. Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. Am J Med. 2011;124(8):724-30. CrossRef PubMed
  6. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67:1016-23. CrossRef PubMed
  7. Jung M, Ma Y, Iver R, DeLeon-Pennell KY, Yabluchiansky A, Garrett MR, Lindsey ML. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112(3):33. DOI:10.1007/ s00395-017-0622-5. CrossRef PubMed PubMedCentral
  8. Biswass S, Ghoshal P, Mandal S, Mandal N. Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction. Korean J Int Med. 2010;25(1):44-50. CrossRef PubMed PubMedCentral
  9. Spitz C, Winkels H, Burger C, Weber C, Lutgens E, Hansson GK, Gerdes N. Regulatory T-cells in atherogenesis: critical immune regulatory function and therapeutic potential. Cell Mol Life Sci. 2016;73(5):901-22. CrossRef PubMed
  10. Gavrilenko TI, Parkhomenko ON, Ryzhkova NO, Kozhukhov SM, Yakushko LV. Citokin's profile of mononuclears at patients by myocardial infarction, complicated cardiac insufficiency. Fisiol Zh. 2012;6: 23-8 [Ukrainian].

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.